Conference - Bangalore, India
The pharmaceutical industry is at an inflexion with momentous changes staring it in the face. In India too, issues with investment, research, and intellectual property indicate a new environment that has both implications and opportunity. The clinical research environment, in particular, has seen ground-shifting changes. New regulations have made the pursuit of clinical development in India extremely challenging. At the same time, demand for services in the regulation-free domains of remote data processing and IT-enabled offerings is growing at an unprecedented scale. A section of the Indian pharmaceutical industry is at the threshold of entry into uncharted territories with global development of innovative assets and biosimilars, even as it braces for headwinds from a struggling global economy and more demanding regulatory requirements. Scientific advances at the genetic and molecular level and enhanced public and non-profit funding are enabling new approaches to public health concerns.
This conference will provide a forum for academia, industry, regulators and researchers to come together to discuss the new environment for health care product development in India – the challenges and the opportunities. Participants will hear about how their peers are coping with new regulations and how they are planning to realize the promise of emerging opportunities.
(Courtesy of Nimhans Convention Center, Bangalore, India, via eventseye.com)
Thu, Oct 24, 2013 - Sat, Oct 26, 2013
Nimhans Convention Center
1st Main Road, Someshwaranagar, Hombegowda Nagar, Bangalore, India
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
